Skip to search formSkip to main contentSkip to account menu

Invokamet

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

MetforminMetformin hydrochloridecanagliflozin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Invokamet (Canagliflozin plus Metformin HCl): First Fixed-Dose Combination with an SGLT2 Inhibitor Approved for the Treatment of Patients with Type 2 Diabetes.
Diabetes is a chronic disease that affects an estimated 29.1 million individuals in the United States—approximately 9.3% of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)